Literature DB >> 8504933

A tissue-specific enhancer confers Pit-1-dependent morphogen inducibility and autoregulation on the pit-1 gene.

S J Rhodes1, R Chen, G E DiMattia, K M Scully, K A Kalla, S C Lin, V C Yu, M G Rosenfeld.   

Abstract

Pit-1 is a tissue-specific POU domain factor obligatory for the appearance of three cell phenotypes in the anterior pituitary gland. Expression of the pit-1 gene requires the actions of a cell-specific 390-bp enhancer, located 10 kb 5' of the pit-1 transcription initiation site, within sequence that proves essential for effective pituitary targeting of transgene expression during murine development. The enhancer requires the concerted actions of a cell-specific cis-active element, Pit-1 autoregulatory sites, and atypical morphogen response elements. Pituitary ontogeny in the Pit-1-defective Snell dwarf mouse reveals that pit-1 autoregulation is not required for initial activation or continued expression during critical phases of Pit-1 target gene activation but, subsequently, is necessary for maintenance of pit-1 gene expression following birth. A potent 1,25-dihydroxyvitamin D3-responsive enhancer element defines a physiological site in which a single nucleotide alteration in the sequence of core binding motifs modulates the spacing rules for nuclear receptor response elements. Unexpectedly, the major retinoic acid response element is absolutely dependent on Pit-1 for retinoic acid receptor function. On this DNA element, Pit-1 appears to function as a coregulator of the retinoic acid receptor, suggesting an intriguing linkage between a cell-specific transcription factor and the actions of morphogen receptors that is likely to be prototypic of mechanisms by which other cell-specific transcription factors might confer morphogen receptor responsivity during mammalian organogenesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8504933     DOI: 10.1101/gad.7.6.913

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  50 in total

Review 1.  Other transcription factors and hypopituitarism.

Authors:  Laurie E Cohen; Sally Radovick
Journal:  Rev Endocr Metab Disord       Date:  2002-12       Impact factor: 6.514

2.  GATA-3 transcriptional imprinting in Th2 lymphocytes: a mathematical model.

Authors:  Thomas Höfer; Holger Nathansen; Max Löhning; Andreas Radbruch; Reinhart Heinrich
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-26       Impact factor: 11.205

Review 3.  From panhypopituitarism to combined pituitary deficiencies: do we need the anterior pituitary?

Authors:  Catherine Carrière; Anatoli Gleiberman; Chijen R Lin; Michael G Rosenfeld
Journal:  Rev Endocr Metab Disord       Date:  2004-03       Impact factor: 6.514

4.  Distinct variant DNA-binding sites determine cell-specific autoregulated expression of the Drosophila POU domain transcription factor drifter in midline glia or trachea.

Authors:  K Certel; M G Anderson; R J Shrigley; W A Johnson
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

5.  Atbf1 is required for the Pit1 gene early activation.

Authors:  Yingchuan Qi; Jeffrey A Ranish; Xiaoyan Zhu; Anna Krones; Jie Zhang; Ruedi Aebersold; David W Rose; Michael G Rosenfeld; Catherine Carrière
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-13       Impact factor: 11.205

Review 6.  Multiple steps in the regulation of transcription-factor level and activity.

Authors:  C F Calkhoven; G Ab
Journal:  Biochem J       Date:  1996-07-15       Impact factor: 3.857

Review 7.  POU domain transcription factors in embryonic development.

Authors:  G J Veenstra; P C van der Vliet; O H Destrée
Journal:  Mol Biol Rep       Date:  1997-08       Impact factor: 2.316

8.  Establishing gene Amelogenin as sex-specific marker in yak by genomic approach.

Authors:  P P Das; G Krishnan; J Doley; D Bhattacharya; S M Deb; P Chakravarty; P J Das
Journal:  J Genet       Date:  2019-03       Impact factor: 1.166

9.  Distinct chromatin configurations regulate the initiation and the maintenance of hGH gene expression.

Authors:  Yugong Ho; Brian M Shewchuk; Stephen A Liebhaber; Nancy E Cooke
Journal:  Mol Cell Biol       Date:  2013-02-19       Impact factor: 4.272

10.  A Pit-1 threonine 220 phosphomimic reduces binding to monomeric DNA sites to inhibit Ras and estrogen stimulation of the prolactin gene promoter.

Authors:  Annie Jean; Arthur Gutierrez-Hartmann; Dawn L Duval
Journal:  Mol Endocrinol       Date:  2009-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.